Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–50 of 65 pages matching "pet"

💊 AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery AlternativesKG

therapeutic · 15,567 words · 67 hyp24 ana25 exp

🧪 PI-2620 Tau PET in PSPKG

clinical · 5,625 words · 4 hyp3 ana7 exp

💊 Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSPKG

therapeutic · 3,527 words · 55 hyp26 ana13 exp

PET Imaging in NeurodegenerationKG

diagnostic · 3,238 words · 278 hyp40 ana200 exp

nct02605785-tau-pet-pspKG

clinical_trial · 2,964 words · 6 hyp5 ana15 exp

⚙️ TSPO PET Imaging for NeuroinflammationKG

mechanism · 2,954 words · 11 hyp36 ana11 exp

apn-1607-tau-pet-phase3-nct07422857KG

clinical_trial · 2,900 words · 10 hyp1 ana6 exp

🧪 XTR006 Tau PET for AD (NCT07115238)KG

clinical · 2,889 words · 12 hyp2 ana5 exp

⚙️ Computational Tau Propagation Model Validation with PET ImagingKG

mechanism · 2,593 words · 16 hyp37 ana14 exp

⚙️ Yin-Yang Hypothesis (O-GlcNAcylation vs. Phosphorylation Competition)KG

mechanism · 2,530 words · 3 hyp33 ana1 exp

Tau PET ImagingKG

diagnostic · 2,495 words · 17 hyp10 ana7 exp

🧪 [F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disease PredictionKG

clinical · 2,349 words · 30 hyp24 ana49 exp

🧬 PET117 — Cytochrome C Oxidase Assembly FactorKG

gene · 2,335 words · 3 hyp2 ana13 exp

💊 Florbetapir (Amyvid) Amyloid PET ImagingKG

therapeutic · 2,230 words · 14 hyp10 ana17 exp

💊 Section 45: Neuroinflammation Imaging and PET Tracers in CBS/PSPKG

therapeutic · 2,209 words · 27 hyp14 ana23 exp

🧪 Longitudinal Multicenter Head-to-Head Harmonization of Tau PET Tracers (NCT05361382)KG

clinical · 2,136 words · 4 hyp1 ana2 exp

tau-pet-4r-tauopathiesKG

general · 2,060 words · 7 hyp3 ana

18F-PM-PBB3 PET Study in Tauopathy (NCT03625128)KG

clinical_trial · 2,037 words · 1 hyp1 ana6 exp

💡 Anti-Herpetic Viral Therapy for Neurodegeneration PreventionKG

idea · 2,009 words · 286 hyp52 ana61 exp

🧪 XTR006 Tau PET for Alzheimer's Disease (NCT07115238)KG

clinical · 1,922 words · 65 hyp25 ana52 exp

📊 Alpha-Synuclein PET Imaging and Biomarker AdvancesKG

biomarker · 1,916 words · 10 hyp5 ana2 exp

💊 Tau PET-Guided Anti-Tau TherapyKG

therapeutic · 1,852 words · 49 hyp22 ana13 exp

🧪 Flornaptitril PET Imaging - Phase 3 (NCT06254469)KG

clinical · 1,789 words · 12 hyp5 ana2 exp

flornaptitril-pet-phase-3-nct06254469KG

clinical_trial · 1,763 words · 4 hyp4 ana1 exp

📊 Tau PET in CBS/PSPKG

biomarker · 1,742 words · 2 hyp5 ana9 exp

Neuroinflammation PET Imaging in CBS/PSPKG

diagnostic · 1,692 words · 171 hyp71 ana22 exp

💊 Section 118: Advanced Neuroinflammation Imaging and PET Tracers in CBS/PSPKG

therapeutic · 1,659 words · 19 hyp13 ana26 exp

⚙️ psp-tau-conformation-pet-imaging-correlationsKG

mechanism · 1,580 words · 34 ana22 exp

🔧 C-BRAIN AI CompetitionKG

technology · 1,558 words · 1 hyp17 ana

Metabolic Imaging and PET Tracers in CBS/PSPKG

general · 1,472 words · 15 hyp13 ana18 exp

⚙️ Validation of Computational Tau Propagation Models Against PET Imaging in PSPKG

mechanism · 1,423 words · 4 hyp37 ana21 exp

📊 AAIC 2026: Tau-PET Imaging and Fluid Biomarker IntegrationKG

biomarker · 1,317 words · 9 hyp4 ana16 exp

🔬 Arcuate NPY/AgRP in AppetiteKG

cell · 1,287 words · 5 hyp5 ana

📊 Amyloid PET Imaging - Diagnostic BiomarkerKG

biomarker · 1,265 words · 176 hyp59 ana18 exp

FDG PET ImagingKG

entity · 1,251 words · 1 ana5 exp

Amyloid PET ImagingKG

entity · 1,240 words · 184 hyp59 ana29 exp

🔧 PET Imaging for Neurodegenerative DiseasesKG

technology · 1,236 words · 11 ana147 exp

TDP-43 PET Ligand Development for Frontotemporal DementiaKG

gap · 1,202 words · 16 ana24 exp

🏥 Tau PET Imaging in Corticobasal SyndromeKG

disease · 1,161 words · 8 hyp7 ana1 exp

🧪 18F-OP-801 Ashvattha Neuroinflammation PET Imaging TrialKG

clinical · 1,102 words · 1 hyp5 ana8 exp

Pain in Parkinson's Disease: Exploration of the Serotonin System in PETKG

clinical_trial · 1,064 words · 61 hyp59 ana59 exp

Tau PET Imaging in Neurodegenerative DiseaseKG

entity · 1,031 words · 15 hyp25 ana12 exp

⚙️ CX3CR1 PET Imaging — Microglia-Targeted NeuroimagingKG

mechanism · 1,026 words · 29 hyp46 ana12 exp

UAB TSPO PET Neuroinflammation in PD TrialKG

clinical_trial · 993 words · 7 hyp4 ana13 exp

🔬 PET100 ProteinKG

protein · 975 words · 3 hyp6 ana

[18F]ACI-15916 PET Alpha-Synucleinopathies Imaging TrialKG

clinical_trial · 972 words · 5 hyp4 ana4 exp

📊 Tau PET Imaging - Clinical Biomarker GuideKG

biomarker · 970 words · 13 hyp11 ana14 exp

🧪 PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical ADKG

clinical · 967 words · 14 hyp6 ana6 exp

🔧 FDG-PET Imaging in NeurodegenerationKG

technology · 932 words · 278 hyp40 ana59 exp

🧫 TDP-43 PET Ligand Development for FTD and ALSKG

experiment · 916 words · 3 hyp13 ana50 exp